v3.22.4
Condensed Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]        
Revenue $ 51,469 $ 45,457 $ 101,072 $ 89,425
Cost of products sold 49,806 43,841 97,795 86,167
Gross margin 1,663 1,616 3,277 3,258
Operating expenses:        
Distribution, selling, general and administrative expenses 1,191 1,151 2,388 2,265
Restructuring and employee severance 17 7 46 25
Amortization and other acquisition-related costs 71 79 142 158
Impairments and (gain)/loss on disposal of assets, net 710 1,295 863 1,293
Litigation (recoveries)/charges, net (207) 34 (180) 52
Operating earnings/(loss) (119) (950) 18 (535)
Other (income)/expense, net (7) (13) (5) (17)
Interest expense, net 25 37 50 77
Loss on early extinguishment of debt 0 0 0 10
(Gain)/loss on sale of equity interest in naviHealth 0 (1) 0 (1)
Earnings/(loss) before income taxes (137) (973) (27) (604)
Benefit from income taxes (7) (1,022) (8) (925)
Net earnings/(loss) (130) 49 (19) 321
Less: Net earnings attributable to noncontrolling interests 0 0 (1) (1)
Net earnings/(loss) attributable to Cardinal Health, Inc. $ (130) $ 49 $ (20) $ 320
Earnings/(Loss) per common share attributable to Cardinal Health, Inc.:        
Basic (in shares) $ (0.50) $ 0.17 $ (0.08) $ 1.13
Diluted (in shares) $ (0.50) $ 0.17 $ (0.08) $ 1.12
Weighted-average number of common shares outstanding:        
Basic (in shares) 261 279 266 283
Diluted (in shares) 261 281 266 285
Cash dividends declared per common share $ 0.4957 $ 0.4908 $ 0.9914 $ 0.9816